Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

35.21
Delayed Data
As of Jun 30
 +0.20 / +0.57%
Today’s Change
28.25
Today|||52-Week Range
36.46
+9.08%
Year-to-Date
Tesaro Stock Up on Successful Phase III Ovarian Cancer Trial
Jun 30 / Zacks.com - Paid Partner Content
10 Companies for Enterprising Dividend Investors - June
Jun 26 / GuruFocus News - Paid Partner Content
McKesson Raises View Due to Accounting Changes, Stock Up
Jun 30 / Zacks.com - Paid Partner Content
The 5 Best Healthcare ETFs
Jun 26 / MotleyFool.com - Paid Partner Content
141 Reasons to Love Biotech Stocks
Jun 30 / MotleyFool.com - Paid Partner Content
Stocks Benjamin Graham Would Buy Today
Jun 24 / GuruFocus News - Paid Partner Content
Pfizer's Rally Is Losing Momentum
Jun 30 / TheStreet.com - Paid Partner Content
Allergan (AGN) Gets FDA Nod for Avycaz Label Expansion
Jun 24 / Zacks.com - Paid Partner Content
AbbVie, J&J's Imbruvica Gets Breakthrough Therapy Status
Jun 30 / Zacks.com - Paid Partner Content
Retrophin (RTRX) RE-024 Positive in Physician-Initiated Study
Jun 24 / Zacks.com - Paid Partner Content
Galena (GALE) Stock Falls on Discontinuation of NeuVax Study
Jun 30 / Zacks.com - Paid Partner Content
AstraZeneca Nasal Spray Flu Vaccine To be Hit By ACIP Vote
Jun 23 / Zacks.com - Paid Partner Content
These Large Pharmaceutical Stocks Should be on your Radar
Jun 29 / Zacks.com - Paid Partner Content
Nymox (NYMX) Stock Up on Positive 7-Year Fexapotide Data
Jun 23 / Zacks.com - Paid Partner Content
Xencor Stock Up On Cancer Drugs Partnership with Novartis
Jun 29 / Zacks.com - Paid Partner Content
Epizyme Teams Up with Roche's Genentech for Tazemetostat
Jun 23 / Zacks.com - Paid Partner Content
McKesson's IT Business to Merge with Change Healthcare
Jun 29 / Zacks.com - Paid Partner Content
RedHill (RDHL) Stock Up on Positive Phase I Data on Yeliva
Jun 22 / Zacks.com - Paid Partner Content
Roche's Multiple Sclerosis Drug Under Review by FDA, EMA
Jun 29 / Zacks.com - Paid Partner Content
Is Opko Health a Buy Now That Rayaldee Is Approved?
Jun 21 / MotleyFool.com - Paid Partner Content
How Pfizer, Merck May Feel Long-term Pinch From Brexit
Jun 29 / TheStreet.com - Paid Partner Content
7 Profitable Medical Stocks Ranked as Buys Now
Jun 21 / Zacks.com - Paid Partner Content
Esperion (ESPR) Offers Updates on LDL-Lowering Candidate
Jun 29 / Zacks.com - Paid Partner Content
7 Pharmaceutical Stocks With Dividends Yielding More Than 3%
Jun 21 / MotleyFool.com - Paid Partner Content
Pfizer's PCSK9 Inhibitor Tops Two Additional Phase III Studies
Jun 29 / Zacks.com - Paid Partner Content
Vical (VICL) Reports Phase I/II Data on Genital Herpes Vaccine
Jun 21 / Zacks.com - Paid Partner Content
Infinity Regains Duvelisib Rights, Announces Restructuring
Jun 29 / Zacks.com - Paid Partner Content
Epizyme Offers Early Data on Non-Hodgkin Lymphoma Drug
Jun 20 / Zacks.com - Paid Partner Content
Company News for June 29, 2016
Jun 29 / Zacks.com - Paid Partner Content
Stock Market News for June 20, 2016
Jun 20 / Zacks.com - Paid Partner Content
Think Healthcare M&A Is Dead? Think Again.
Jun 28 / MotleyFool.com - Paid Partner Content
Emergent (EBS) BioThrax sBLA Accepted for FDA Review
Jun 20 / Zacks.com - Paid Partner Content
Pfizer Investing $350M in China, Setting up Biotech Center
Jun 28 / Zacks.com - Paid Partner Content
3 Top Big Pharma Stocks to Buy Now
Jun 19 / MotleyFool.com - Paid Partner Content
5 Medical Stocks to Buy with Great Dividend Yields
Jun 28 / Zacks.com - Paid Partner Content
Wall Street heads for second straight weekly loss
Jun 17 / FT.com - Paid Partner Content
Pfizer (PFE) Stock Gains on China Investment
Jun 28 / TheStreet.com - Paid Partner Content
Paratek Reports Positive Phase III Data on Antibiotic Drug
Jun 17 / Zacks.com - Paid Partner Content
Forget Stem Cell Stocks: Here Are 3 Clinical-Stage Biotechs to Buy Instead
Jun 28 / MotleyFool.com - Paid Partner Content
Medivation's (MDVN) Pidilizumab Positive in Phase I/II Study
Jun 17 / Zacks.com - Paid Partner Content
Puma (PBYI) Submits Neratinib Marketing Application in EU
Jun 28 / Zacks.com - Paid Partner Content
Cancer therapy re-engineers cells to hunt and destroy
Jun 02 / FT.com - Paid Partner Content
GW Pharmaceuticals Stock Up on Positive Epidiolex Data
Jun 28 / Zacks.com - Paid Partner Content
President raises patient and business hope for cancer treatment
Jun 02 / FT.com - Paid Partner Content
Best Stocks to Buy in a Crash
Jun 27 / MotleyFool.com - Paid Partner Content
M&A back on the table as 'big pharma' targets smaller rivals
Jun 02 / FT.com - Paid Partner Content
Sanofi Inks Deal to Swap Business with Boehringer Ingelheim
Jun 27 / Zacks.com - Paid Partner Content
Cancer doctors face next drug challenge
Jun 01 / FT.com - Paid Partner Content
Teva's Cinqaero Gets Positive CHMP View, Decision in 2H16
Jun 27 / Zacks.com - Paid Partner Content